SCHEMBL115233

SCHEMBL115233

COC(=O)C=C(C)CCC=C(C)C

nearest known ligand 0.62

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.62
ATM Q13315 1/20 0.62
POLB P06746 1/20 0.60
ALDH1A1 P00352 3/20 0.52
ALOX15 P16050 3/20 0.52
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.47
CYP3A4 P08684 2/20 0.47
FNTA P49354 6/20 0.46
FNTB P49356 6/20 0.46
MAPT P10636 2/20 0.45
UGT1A1 P22309 1/20 0.45
TRPV1 Q8NER1 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17629195 1.00 KDM4E (0.62) KDM4EATMPOLBALDH1A1ALOX15
SCHEMBL1154071 1.00 KDM4E (0.62) KDM4EATMPOLBALDH1A1ALOX15
SCHEMBL5856997 0.96 KDM4E (0.58) KDM4EATMPOLBALDH1A1ALOX15
SCHEMBL2023438 0.96 KDM4E (0.58) KDM4EATMPOLBALDH1A1ALOX15
SCHEMBL10181090 0.96 KDM4E (0.58) KDM4EATMPOLBALDH1A1ALOX15
SCHEMBL11578341 0.96 KDM4E (0.58) KDM4EATMPOLBALDH1A1ALOX15
SCHEMBL12266823 0.96 KDM4E (0.58) KDM4EATMPOLBALDH1A1ALOX15
SCHEMBL29578463 0.86 KDM4E (0.64) KDM4EATMPOLBALDH1A1ALOX15
SCHEMBL22545319 0.85 KDM4E (0.58) KDM4EATMPOLBALDH1A1ALOX15
SCHEMBL11549444 0.85 KDM4E (0.44) KDM4EATMPOLBALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1086 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4519404-A1 METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN Firmenich SA (CH) 2025-03-12 EP claimed
CN-119403908-A Method for enhancing psychological performance and composition for use in the method 弗门尼舍有限公司 2025-02-07 CN claimed
CN-111051483-B Esters and ethers of 2, 4-tetramethyl cyclobutane-1, 3-diol as fragrance chemicals 巴斯夫欧洲公司 2025-01-24 CN claimed
US-12187978-B2 Use of (3-acetoxy-2,2-dimethyl-propyl) acetate in combination with (3-hydroxy-2,2-dimethyl-propyl) acetate as an aroma chemical BASF SE (DE) 2025-01-07 US claimed
WO-2023247604-A1 METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN FIRMENICH SA (CH) 2023-12-28 WO claimed
CN-116426338-A Spice mainly with grass aroma and flavor, preparation method thereof and application thereof in cigarettes 云南中烟工业有限责任公司 2023-07-14 CN claimed
CN-109152711-B Method for producing perfume capsules with improved surfactant stability 西姆莱斯股份公司 2021-10-22 CN claimed
CN-113056547-A Jasmine alcohol 西姆莱斯有限公司 2021-06-29 CN claimed
US-10876081-B2 Method for the production of scent capsules with improved surfactant stability SYMRISE AG (DE) 2020-12-29 US claimed
EP-3423028-B1 METHOD FOR THE PRODUCTION OF ENCAPSULATED FRAGRANCE WITH IMPROVED STABILITY AGAINST DETERGENTS SYMRISE AG (DE) 2020-04-08 EP claimed
WO-2020015880-A1 BI-PHASE DEODORIZING COSMETIC COMPOSITION BEIERSDORF AG (DE) 2020-01-23 WO claimed
EP-3423028-A1 METHOD FOR THE PRODUCTION OF SCENT CAPSULES WITH IMPROVED SURFACTANT STABLITY Symrise AG (DE) 2019-01-09 EP claimed
CN-109152711-A Method for producing perfume capsules with improved surfactant stability 西姆莱斯股份公司 2019-01-04 CN claimed
WO-2011147455-A1 FLAVORING SUBSTANCE-INCLUDED COMPOUNDS SYMRISE AG (DE) 2011-12-01 WO claimed
US-8034761-B2 Jasmone, peach fragrance SYMRISE AG (DE) 2011-10-11 US claimed
US-12630783-B2 Muguet type fragrance compounds SYMRISE AG (DE) 2026-05-19 US disclosed
US-12630781-B2 Fragrance or flavour mixture SYMRISE AG (DE) 2026-05-19 US disclosed
WO-2001023373-A2 1,4-DIOXACYCLOALKANE-2-ONE AND 1,4-DIOXACYCLOALKENE-2-ONE HAARMANN & REIMER GMBH (DE) 2001-04-05 WO disclosed
EP-1067126-A2 Tetracyclic acetals HAARMANN & REIMER GMBH (DE) 2001-01-10 EP disclosed
US-4137273-A INSECTICIDES, CHEMICAL INTERMEDIATES ZOECON CORPORATION (US) 1979-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630783-B2 Muguet type fragrance compounds MGAT1, RFT1, CPT1A KDM4E 590/4885ATM 4367/4885POLB 930/4885
US-10876081-B2 Method for the production of scent capsules with improved surfactant stability SMOX, LIPA, SGMS2 KDM4E 2386/4885ATM 2538/4885POLB 950/4885
US-12630781-B2 Fragrance or flavour mixture NOTUM, FFAR2, FFAR1 KDM4E 2767/4885ATM 1622/4885POLB 406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.